{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:39:57Z","timestamp":1792517997524,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["DE230101210"],"award-info":[{"award-number":["DE230101210"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001350","name":"Ministry of Health -Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001350","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.vaccine.2026.128513","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T08:00:02Z","timestamp":1774684802000},"page":"128513","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Long-term impacts of HPV vaccination strategies on HPV related Cancer burden among Singaporean female population: A prospective simulation using proportional multistate lifetables"],"prefix":"10.1016","volume":"80","author":[{"given":"Upul","family":"Cooray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco A.","family":"Peres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2026.128513_bb0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1478-7954-1-4","article-title":"A generic model for the assessment of disease epidemiology: the computational basis of DisMod II","volume":"1","author":"Barendregt","year":"2003","journal-title":"Popul Health Metr"},{"key":"10.1016\/j.vaccine.2026.128513_bb0010","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2334-13-373","article-title":"Comparing human papillomavirus prevalences in women with normal cytology or invasive cervical cancer to rank genotypes according to their oncogenic potential: a meta-analysis of observational studies","volume":"13","author":"Bernard","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128513_bb0015","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1093\/ije\/dyaa132","article-title":"Proportional multistate lifetable modelling of preventive interventions: concepts, code and worked examples","volume":"49","author":"Blakely","year":"2020","journal-title":"Int J Epidemiol"},{"issue":"17","key":"10.1016\/j.vaccine.2026.128513_bb0020","first-page":"3805","article-title":"Status of HPV disease and vaccination programmes in LMICs: introduction to special issue","volume":"42","author":"Borda","year":"2024","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2026.128513_bb0025","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1086\/657321","article-title":"Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings","volume":"202","author":"Bruni","year":"2010","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128513_bb0030","first-page":"983","article-title":"Human papillomavirus and rising oropharyngeal cancer incidence in the United States","volume":"41","author":"Chaturvedi","year":"2023","journal-title":"J Clin Oncol"},{"issue":"14","key":"10.1016\/j.vaccine.2026.128513_bb0035","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/cncr.31383","article-title":"A snapshot of the evolving epidemiology of oropharynx cancers","volume":"124","author":"Chaturvedi","year":"2018","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128513_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16010226","article-title":"Changes in the incidence and human papillomavirus-positive portion of oropharyngeal squamous cell carcinoma in Hong Kong","volume":"16","author":"Chen","year":"2024","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128513_bb0045","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/epirev\/mxj006","article-title":"Mathematical models for predicting the epidemiologic and economic impact of vaccination against human papillomavirus infection and disease","volume":"28","author":"Dasbach","year":"2006","journal-title":"Epidemiol Rev"},{"issue":"10","key":"10.1016\/j.vaccine.2026.128513_bb0050","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3390\/v9100300","article-title":"Random network models to predict the long-term impact of HPV vaccination on genital warts","volume":"9","author":"D\u00edez-Domingo","year":"2017","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128513_bb0055","doi-asserted-by":"crossref","first-page":"508","DOI":"10.47102\/annals-acadmedsg.2020499","article-title":"Trends in HPV-related oropharyngeal cancers in Singapore","volume":"50","author":"Fu","year":"2021","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.vaccine.2026.128513_bb0060","author":"GBD"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128513_bb0065","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1056\/NEJMoa0909537","article-title":"Efficacy of Quadrivalent HPV vaccine against HPV infection and disease in males","volume":"364","author":"Giuliano","year":"2011","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128513_bb0070","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1016\/S1470-2045(14)70481-4","article-title":"Present status of human papillomavirus vaccine development and implementation","volume":"16","author":"Herrero","year":"2015","journal-title":"Lancet Oncology"},{"issue":"8","key":"10.1016\/j.vaccine.2026.128513_bb0075","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1002\/ijc.23712","article-title":"Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark","volume":"123","author":"Kj\u00e6r","year":"2008","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128513_bb0080","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/sj.bjc.6603501","article-title":"Estimating the long-term impact of a prophylactic human papillomavirus 16\/18 vaccine on the burden of cervical Cancer in the UK","volume":"96","author":"Kohli","year":"2007","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128513_bb0085","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/1471-2458-11-203","article-title":"Cost-effectiveness of different human papillomavirus vaccines in Singapore","volume":"11","author":"Lee","year":"2011","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2026.128513_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2025.1633975","article-title":"Global, regional, and national disease burden and economic costs of cervical cancer (1991\u20132021): a multidimensional data synthesis analysis","volume":"13","author":"Ma","year":"2025","journal-title":"Front Public Health"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128513_bb0095","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/infdis\/jiw256","article-title":"Public health benefits of routine human papillomavirus vaccination for adults in the Netherlands: a mathematical modeling study","volume":"214","author":"Matthijsse","year":"2016","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2026.128513_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202924","article-title":"The health impact of human papillomavirus vaccination in the situation of primary human papillomavirus screening: a mathematical modeling study","volume":"13","author":"Matthijsse","year":"2018","journal-title":"PloS One"},{"issue":"9","key":"10.1016\/j.vaccine.2026.128513_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens14090880","article-title":"Global burden and incidence trends in cancers associated with human papillomavirus infection: a population-based systematic study","volume":"14","author":"Meng","year":"2025","journal-title":"Pathogens"},{"key":"10.1016\/j.vaccine.2026.128513_bb0110","article-title":"Towards elimination of cervical cancer: human papillomavirus (HPV) vaccination and cervical cancer screening in Asian National Cancer Centers Alliance (ANCCA) member countries","volume":"38","author":"Ong","year":"2023","journal-title":"Lancet Reg Health-West Pac"},{"key":"10.1016\/j.vaccine.2026.128513_bb0115","article-title":"Economic value of lost productivity attributable to human papillomavirus Cancer mortality in the United States","volume":"8","author":"Priyadarshini","year":"2020","journal-title":"Front Public Health"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128513_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9051305","article-title":"Association of salivary human papillomavirus infection and oral and oropharyngeal cancer: a meta-analysis","volume":"9","author":"Rapado-Gonz\u00e1lez","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.vaccine.2026.128513_bb0125","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1080\/13696998.2025.2528518","article-title":"The productivity loss associated with HPV-related cancer mortality in Europe; years of life lost and productivity costs","volume":"27","author":"Sabale","year":"2024","journal-title":"J Med Econ"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128513_bb0130","first-page":"7","article-title":"Human papillomavirus and cancerous diseases of the head and neck: a systematic review and Meta-analysis","volume":"21","author":"Saulle","year":"2015","journal-title":"Oral Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128513_bb0135","first-page":"388","article-title":"Impact of tax and tobacco-free generation on health-adjusted life years in the Solomon Islands: a multistate life table simulation","volume":"29","author":"Singh","year":"2020","journal-title":"Tob Control"},{"issue":"33","key":"10.1016\/j.vaccine.2026.128513_bb0140","first-page":"918924","article-title":"Trends in human papillomavirusassociated cancers United States, 19992015","volume":"67","author":"Van Dyne","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128513_bb0145","doi-asserted-by":"crossref","first-page":"294","DOI":"10.11622\/smedj.2022053","article-title":"Improved population coverage of the human papillomavirus vaccine after implementation of a school-based vaccination Programme: the Singapore experience","volume":"64","author":"Vijayalakshmi","year":"2022","journal-title":"Singapore Med J"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128513_bb0150","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.adaj.2019.10.010","article-title":"Summary of the evidence on the safety, efficacy, and effectiveness of human papillomavirus vaccines: umbrella review of systematic reviews","volume":"151","author":"Villa","year":"2020","journal-title":"J Am Dent Assoc"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128513_bb0155","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/sj.bjc.6603469","article-title":"High sustained efficacy of a prophylactic Quadrivalent human papillomavirus types 6\/11\/16\/18 L1 virus-like particle vaccine through 5 years of follow-up","volume":"95","author":"Villa","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.vaccine.2026.128513_bb0160","series-title":"Global strategy to accelerate the elimination of cervical Cancer as a public health problem","author":"World Health Organization","year":"2020"},{"key":"10.1016\/j.vaccine.2026.128513_bb0165","doi-asserted-by":"crossref","first-page":"15386","DOI":"10.18632\/oncotarget.24169","article-title":"Prevalence of human papillomavirus genotypes and relative risk of cervical Cancer in China: a systematic review and Meta-analysis","volume":"9","author":"Xu","year":"2018","journal-title":"Oncotarget"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2600321X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2600321X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:02:20Z","timestamp":1792515740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2600321X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":33,"alternative-id":["S0264410X2600321X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128513","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term impacts of HPV vaccination strategies on HPV related Cancer burden among Singaporean female population: A prospective simulation using proportional multistate lifetables","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128513","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128513"}}